Illumina is down 15.2% since the beginning of the year, and at $111.06 per share, it is trading 28.4% below its 52-week high of $155.15 from November 2024. Investors who bought $1,000 worth of ...

Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...

(RTTNews) - Below are the earnings highlights for Illumina Inc. (ILMN): Earnings: $187 million in Q4 vs. -$176 million in the same period last year. EPS: $1.17 in Q4 vs. -$1.11 in the same period ...

CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted significant advancements ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

To be successful, health care organizations ... Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...

SAN FRANCISCO/NEW YORK, Feb 10 (Reuters) - OpenAI is pushing ahead on its plan to reduce its reliance on Nvidia (NVDA.O), opens new tab for its chip supply by developing its first generation of in ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

It won't be surprising to see more companies adopting Broadcom's custom AI chip designs in a bid to reduce costs following DeepSeek's popularity. After all, DeepSeek has employed a method of ...